NBY

NovaBay Pharmaceuticals Inc

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

NBY price

NovaBay Pharmaceuticals Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NBY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NBY

Valuation

P/E

0.00

Sector 1.03

Industry 14.35

P/BV

0.00

Sector 1.86

Industry 2.57

P/Revenue (PSR)

Sector 1.55

Industry 1.15

EV/EBITDA

Sector -28.64

Industry 26.90

EV/EBIT

Sector -28.82

Industry -31.74

P/EBITDA

Sector -32.29

Industry -9.26

P/EBIT

Sector -42.75

Industry 0.24

P/Total Assets

Sector 0.87

Industry 1.15

P/Net Current Assets

Sector -27.31

Industry -3.76

P/Working Capital

Sector -3.97

Industry 6.12

EPS

-0.22

Sector -0.71

Industry 1.27

BVPS

5.34

Sector 4.32

Industry 15.27

Efficiency

Gross Margin

-0.87%

Sector 49.17%

Industry 35.74%

EBITDA Margin

Sector -308.54%

Industry 5.37%

EBIT Margin

-0.13%

Sector -178.98%

Industry 3.08%

Operating Margin

-58.93%

Sector -20.11%

Industry 2.20%

Net Profit Margins

-63.26%

Sector -24.57%

Industry 3.24%

Asset Turnover

0.01

Sector 0.13

Industry 0.28

Profitability

ROE

-4.21%

Sector -24.85%

Industry 8.71%

ROA

-3.25%

Sector -24.72%

Industry 3.75%

ROIC

Sector -587.46%

Industry -2.36%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

Sector -

Industry 0.62%

Debt

Current Ratio

Sector 1.92

Industry 1.48

Net Debt / EBITDA

Sector -5.39

Industry -10.12

Net Debt / EBIT

Sector -3.29

Industry -6.30

Net Debt / Equity

Sector -0.46

Industry -0.04

Gross Debt / Equity

Sector -0.73

Industry 0.29

Equity/Assets

0.77

Sector 0.46

Industry 0.46

Liabilities/Assets

0.23

Sector 0.49

Industry 0.52

Growth

5Y Revenue CAGR

0.87%

Sector -

Industry -

5Y Earnings CAGR

-2.29%

Sector -

Industry -

Fundamentals NBY

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NBY NovaBay Pharmaceuticals Inc	$0.00	-100.00%	0.00%	0.00	0.00	-4.21%	-63.26%
LLY Eli Lilly and Compay	$1,141.58	52.08%	0.59%	37.57	29.62	78.84%	33.53%
SNY Sanofi	$42.70	-5.63%	4.16%	3.98	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.00	28.05%	3.68%	14.78	4.17	28.24%	14.54%
CRMD CorMedix Inc.	$7.81	-39.68%	0.00%	3.35	1.36	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.77	-15.29%	0.00%	13.15	1.34	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$11.63	-20.10%	0.70%	27.08	2.44	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.90	-94.41%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$376.19	-16.34%	0.00%	41.36	7.14	17.26%	28.62%
NVS Novartis AG	$138.72	13.93%	2.25%	20.58	6.25	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$635.59	33.14%	0.29%	32.54	4.31	13.25%	15.07%
ABT Abbott Laboratories	$101.91	-20.63%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$94.30	4.33%	3.17%	21.85	2.26	10.35%	14.02%
BSX Boston Scientific Corp.	$43.87	-57.29%	0.00%	17.35	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$90.08	-21.37%	0.00%	18.39	5.39	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$511.38	-20.24%	0.00%	34.83	24.62	70.67%	25.03%
RMD ResMed Inc.	$233.73	-12.38%	1.11%	20.57	4.76	23.13%	26.94%
HCA HCA Healthcare Inc.	$424.84	5.56%	0.70%	11.97	-29.30	-244.72%	10.07%
COHR Coherent Inc.	$272.28	164.38%	0.00%	74.57	5.29	7.09%	11.19%
DHR Danaher Corporation	$208.40	11.35%	0.71%	35.51	2.70	7.61%	15.95%
SYK Stryker Corp.	$280.58	-25.85%	1.29%	27.75	4.31	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NBY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000
Dividends	09/29/2025	09/29/2025	4.00000000

ABOUT NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc

Average Investor10 user rating

4.0 (6 people)

United States

- year

Founded:

2007

Time since IPO - 19 years

2

Employees

NovaBay Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $138.83 million.

The company employs approximately 2 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, NovaBay Pharmaceuticals Inc reported $9.24 million in revenue, generating net income of $-5.84 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NBY.

Market cap

Net worth

$138.83 million

$138,825,000.00

Assets

$179.74 million

$179,743,000.00

Total Shares Outstanding

26.02 million

26,015,000

Average Daily Trading Volume

$554.45 Thousand

$554,450.00

Sector

Health

Industry

Pharmaceutical Products

NBY

NBY revenue and profits

Financial Results NBY

DRAG THE FRAME TO SEE MORE DATA

NBY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$94.73 33,02% (12M)

P/E

-0.84

2.82%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$289.94 0,28% (12M)

P/E

10.69

2.22%

ROE

16.04%

P/BV

1.72

CNC - Centene

$67.36 106,37% (12M)

P/E

-6.30

0.00%

ROE

-22.56%

P/BV

1.42

HUM - Humana

$394.22 45,52% (12M)

P/E

37.65

0.87%

ROE

6.72%

P/BV

2.53

SNY - Sanofi

$42.70 --4,78% (12M)

P/E

3.98

4.16%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,141.58 53,54% (12M)

P/E

37.57

0.59%

ROE

78.84%

P/BV

29.62

HCA - HCA Healthcare

$424.84 6,07% (12M)

P/E

11.97

0.70%

ROE

-244.72%

P/BV

-29.30

NVS - Novartis

$138.72 14,68% (12M)

P/E

20.58

2.25%

ROE

30.39%

P/BV

6.25